Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04571151
What this trial is testing

Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Skin Sciences, PLLC 30
Large-scale testing (Phase 3)Study completedNCT04839328
What this trial is testing

A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Tianjin Hemay Pharmaceutical Co., Ltd 306
Testing effectiveness (Phase 2)Study completedNCT02070965
What this trial is testing

DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Primus Pharmaceuticals 75
Large-scale testing (Phase 3)Study completedNCT03611751
What this trial is testing

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 1,020
Large-scale testing (Phase 3)Study completedNCT00679731
What this trial is testing

Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie (prior sponsor, Abbott) 317
Post-approval studies (Phase 4)Study completedNCT00842153
What this trial is testing

Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam

Who this might be right for
Psoriasis
Stiefel, a GSK Company 58
Large-scale testing (Phase 3)Study completedNCT03364309
What this trial is testing

Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 438
Post-approval studies (Phase 4)Not Yet RecruitingNCT07373847
What this trial is testing

Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia

Who this might be right for
Plaque Psoriasis
Xiangya Hospital of Central South University 40
Not applicableStudy completedNCT00749398
What this trial is testing

Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 133
Large-scale testing (Phase 3)Study completedNCT03308799
What this trial is testing

A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream

Who this might be right for
Psoriasis Vulgaris
MC2 Therapeutics 794
Post-approval studies (Phase 4)Study completedNCT01511315
What this trial is testing

The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment

Who this might be right for
Psoriasis
University of California, San Francisco 36
Post-approval studies (Phase 4)Study completedNCT03573323
What this trial is testing

Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 1,027
Large-scale testing (Phase 3)Study completedNCT01763424
What this trial is testing

Nicotinamide in the Treatment of Psoriasis

Who this might be right for
Psoriasis
Isfahan University of Medical Sciences 66
Testing effectiveness (Phase 2)Study completedNCT05357755
What this trial is testing

JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 90
Testing effectiveness (Phase 2)Study completedNCT03635099
What this trial is testing

This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is

Who this might be right for
Psoriasis
Boehringer Ingelheim 274
Early research (Phase 1)Study completedNCT06182384
What this trial is testing

A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices

Who this might be right for
Moderate-to-Severe Plaque Psoriasis
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 46
Post-approval studies (Phase 4)Study completedNCT00791765
What this trial is testing

Moderate to Severe Plaque Psoriasis With Scalp Involvement

Who this might be right for
Psoriasis
Amgen 124
Testing effectiveness (Phase 2)Study completedNCT02295865
What this trial is testing

Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 62
Not applicableStudy completedNCT03026153
What this trial is testing

Biologics Anchoring Study

Who this might be right for
Moderate-to-severe Psoriasis
Wake Forest University Health Sciences 100
Large-scale testing (Phase 3)Study completedNCT02207231
What this trial is testing

Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 837
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation